These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 17475919)
41. The readthrough variant of acetylcholinesterase remains very minor after heat shock, organophosphate inhibition and stress, in cell culture and in vivo. Perrier NA; Salani M; Falasca C; Bon S; Augusti-Tocco G; Massoulié J J Neurochem; 2005 Aug; 94(3):629-38. PubMed ID: 16001972 [TBL] [Abstract][Full Text] [Related]
42. In vitro investigation of efficacy of new reactivators on OPC inhibited rat brain acetylcholinesterase. Atanasov VN; Petrova I; Dishovsky C Chem Biol Interact; 2013 Mar; 203(1):139-43. PubMed ID: 23220589 [TBL] [Abstract][Full Text] [Related]
43. In vitro protection of red blood cell acetylcholinesterase by metoclopramide from inhibition by organophosphates (paraoxon and mipafox). Petroianu G; Arafat K; Kosanovic M; Saleh A; Camasamudram V; Hasan MY J Appl Toxicol; 2003; 23(6):447-51. PubMed ID: 14635269 [TBL] [Abstract][Full Text] [Related]
44. Polyethylene-glycol conjugated recombinant human acetylcholinesterase serves as an efficacious bioscavenger against soman intoxication. Kronman C; Cohen O; Raveh L; Mazor O; Ordentlich A; Shafferman A Toxicology; 2007 Apr; 233(1-3):40-6. PubMed ID: 17045722 [TBL] [Abstract][Full Text] [Related]
45. Reactivation and aging of phosphorylated brain acetylcholinesterase from fish and rodents. Wallace KB; Herzberg U Toxicol Appl Pharmacol; 1988 Feb; 92(2):307-14. PubMed ID: 3341039 [TBL] [Abstract][Full Text] [Related]
46. Comparison of the in vitro sensitivity of rat acetylcholinesterase to chlorpyrifos-oxon: what do tissue IC50 values represent? Mortensen SR; Brimijoin S; Hooper MJ; Padilla S Toxicol Appl Pharmacol; 1998 Jan; 148(1):46-9. PubMed ID: 9465262 [TBL] [Abstract][Full Text] [Related]
47. Comparison of chlorpyrifos-oxon and paraoxon acetylcholinesterase inhibition dynamics: potential role of a peripheral binding site. Kousba AA; Sultatos LG; Poet TS; Timchalk C Toxicol Sci; 2004 Aug; 80(2):239-48. PubMed ID: 15141101 [TBL] [Abstract][Full Text] [Related]
48. Next generation OP-bioscavengers: a circulatory long-lived 4-PEG hypolysine mutant of F338A-HuAChE with optimal pharmacokinetics and pseudo-catalytic characteristics. Kronman C; Cohen O; Mazor O; Ordentlich A; Raveh L; Velan B; Shafferman A Chem Biol Interact; 2010 Sep; 187(1-3):253-8. PubMed ID: 20005217 [TBL] [Abstract][Full Text] [Related]
49. Synaptic remodeling at the skeletal neuromuscular junction of acetylcholinesterase knockout mice and its physiological relevance. Girard E; Barbier J; Chatonnet A; Krejci E; Molgó J Chem Biol Interact; 2005 Dec; 157-158():87-96. PubMed ID: 16274683 [TBL] [Abstract][Full Text] [Related]
50. Potential of two new oximes in reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by organophosphate compounds: an in vitro study. Costa MD; Freitas ML; Soares FA; Carratu VS; Brandão R Toxicol In Vitro; 2011 Dec; 25(8):2120-3. PubMed ID: 21983245 [TBL] [Abstract][Full Text] [Related]
51. Detoxification of Organophosphate Poisoning Using Nanoparticle Bioscavengers. Pang Z; Hu CM; Fang RH; Luk BT; Gao W; Wang F; Chuluun E; Angsantikul P; Thamphiwatana S; Lu W; Jiang X; Zhang L ACS Nano; 2015 Jun; 9(6):6450-8. PubMed ID: 26053868 [TBL] [Abstract][Full Text] [Related]
53. A Study of the Protective Properties of an Antibody-Based Antidote Metabolizing Organophosphorus Pesticide Paraoxon. Mokrushina YA; Stepanova AV; Palikov VA; Stepanov AV; Belous GI; Dyachenko IA; Knorre VD; Smirnov IV; Gabibov AG Bull Exp Biol Med; 2017 Jun; 163(2):218-221. PubMed ID: 28726199 [TBL] [Abstract][Full Text] [Related]
54. Effects of chronic dermal exposure to nonlethal doses of methyl parathion on brain regional acetylcholinesterase and muscarinic cholinergic receptors in female rats. Ma T; Kramer RE; Baker RC; Fan LW; Ho IK J Neurosci Res; 2003 Jan; 71(1):138-45. PubMed ID: 12478623 [TBL] [Abstract][Full Text] [Related]
55. Minireview: does in-vitro testing of oximes help predict their in-vivo action after paraoxon exposure? Lorke DE; Petroianu GA J Appl Toxicol; 2009 Aug; 29(6):459-69. PubMed ID: 19603416 [TBL] [Abstract][Full Text] [Related]
56. Acetylcholinesterase prophylaxis against organophosphate toxicity. Wolfe AD; Rush RS; Doctor BP; Koplovitz I; Jones D Fundam Appl Toxicol; 1987 Aug; 9(2):266-70. PubMed ID: 3653568 [TBL] [Abstract][Full Text] [Related]
57. Origin of acetylcholinesterase in the neuromuscular junction formed in the in vitro innervated human muscle. Jevsek M; Mars T; Mis K; Grubic Z Eur J Neurosci; 2004 Dec; 20(11):2865-71. PubMed ID: 15579140 [TBL] [Abstract][Full Text] [Related]
58. Paraoxon toxicity is not potentiated by prior reduction in blood acetylcholinesterase. Padilla S; Moser VC; Pope CN; Brimijoin WS Toxicol Appl Pharmacol; 1992 Nov; 117(1):110-5. PubMed ID: 1440604 [TBL] [Abstract][Full Text] [Related]
60. In vitro and in vivo protection of acetylcholinesterase against organophosphate poisoning by pretreatment with a novel derivative of 1,3,2-dioxaphosphorinane 2-oxide. Ashani Y; Leader H; Raveh L; Bruckstein R; Spiegelstein M J Med Chem; 1983 Feb; 26(2):145-52. PubMed ID: 6827532 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]